中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
MeSH:(Darunavir)

1.Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus.

Sang Ah LEE ; Shin Woo KIM ; Hyun Ha CHANG ; Hyejin JUNG ; Yoonjung KIM ; Soyoon HWANG ; Sujeong KIM ; Han Ki PARK ; Jong Myung LEE

Infection and Chemotherapy 2018;50(3):252-262

2.Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China.

Yong-Zheng GUO ; Kai-Jin XU ; Yong-Tao LI ; Jia-Dan FU ; Min XU ; Ling YU ; Ji-Fang SHENG ; Biao ZHU

Journal of Zhejiang University. Science. B 2020;21(12):948-954

3.Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus.

Sang Ah LEE ; Shin Woo KIM ; Hyun Ha CHANG ; Hyejin JUNG ; Yoonjung KIM ; Soyoon HWANG ; Sujeong KIM ; Han Ki PARK ; Jong Myung LEE

Infection and Chemotherapy 2018;50(3):252-262

4.The Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART Regimens.

Sun JIN ; Myung Hi KIM ; Jung Hwa PARK ; Hye Jin JUNG ; Hye Jin LEE ; Shin Woo KIM ; Jong Myung LEE ; Sujeong KIM ; Hyun Ha CHANG

Infection and Chemotherapy 2015;47(4):239-246

5.Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by Efavirenz.

Lawrence S U LEE ; Paul PHAM ; Charles FLEXNER

Annals of the Academy of Medicine, Singapore 2012;41(12):559-562

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO